Viewing nowSelnapin Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201900799 · Approved 2019.02.01 · Insurance code 693902950
Treatment of dermatophyte infections (athlete's foot, ringworm, etc.) and onychomycosis
This medication is used to treat athlete's foot, ringworm, tinea capitis, and onychomycosis caused by dermatophyte fungi in adults. It is also effective in treating tinea capitis in children. In other words, it is used to treat fungal infections of the skin and nails.
Administer 125 mg of terbinafine per dose, twice a day, or 250 mg per dose, once a day. The treatment duration depends on the condition as follows: 1) Dermatophyte infections: athlete's foot (interdigital, plantar/moccasin type) 2-6 weeks, ringworm 2-4 weeks, tinea capitis 2-4 weeks. 2) Onychomycosis: typically administered for 6 weeks to 3 months. In cases of infection in the fingernail or smaller toes, or younger patients, the duration may be less than 3 months.
Administer to children over the age of 2. Not recommended for children under 2 due to lack of experience. Tinea capitis primarily occurs in children, and the treatment duration is 4 weeks. 1) Body weight under 20 kg (under 5 years): 1
This medicine is not recommended for patients with chronic liver disease or active liver disease. Make sure to check if there is a history of liver disease before administration and conduct regular liver function tests. If symptoms of liver dysfunction appear, discontinue the medication immediately and consult a doctor. This medication can cause serious liver damage, such as liver failure, so caution is required. This medication should not be administered to patients with allergies to this medicine or its components, patients with chronic liver disease, hematological disorders, severe renal failure, nursing mothers, infants under 2 years of age, or patients with certain genetic lactose intolerance. Caution should be exercised when administering to patients with impaired renal function, elderly patients, children weighing less than 20 kg, psoriasis, or systemic lupus erythematosus patients, and if serious skin reactions occur, the medication should be discontinued immediately. This medication can cause various side effects such as liver dysfunction, blood disorders, skin rashes, muscle pain, gastrointestinal symptoms, mental changes, and neurological abnormalities; therefore, if any abnormal symptoms appear, notify a doctor immediately. Caution is needed when driving or operating machinery as dizziness and other side effects may occur. This medication may interact with other drugs, requiring dosage adjustments and caution during concomitant use. In particular, when used together with medications metabolized in the liver, follow your doctor's instructions. Women who are pregnant or may become pregnant should use this medication cautiously, and nursing mothers should discontinue breastfeeding while using it. Experience in administering to infants under 2 years is lacking, hence not recommended. Care should be taken when administering to children and the elderly. In case of overdose, symptoms may include headache, nausea, abdominal pain, and dizziness, requiring immediate medical attention. Store this medicine out of reach of children and keep it in a tightly closed container, avoiding direct sunlight and storing it at room temperature.
Rash, itching, photosensitivity reactions, musculoskeletal reactions (arthralgia, myalgia), muscle pain, weakness, elevated CPK, elevated myoglobin in blood and urine, hypotension, erythema, facial edema, lymphangiectasia, gastrointestinal symptoms (abdominal bloating, decreased appetite, indigestion, nausea, mild abdominal pain, diarrhea), dyspepsia, vomiting, glossitis, depression, anxiety, headache, taste disorders, dizziness, drowsiness, sensory abnormalities, sensory loss, attention impairment
Not everyone experiences these, and they can vary from person to person.
Store this medicine in a tightly closed container to prevent exposure to air, ideally at room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be well maintained.
White round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.